Prostate Diseases

Benign Prostatic Hypertrophy; Prostate Disease; Prostate Enlargement; Prostatitis

Clinical Trial: ZD4054 in Pain-free or Mildly Symptomatic Patients with Prostate Cancer and Bone Metastases who have Rising Serum Prostate Specific Antigen (PSA)

Jump to Section

Purpose
Eligibility
Location and Contact Information
More Information

This study is currently recruiting patients.

Sponsored by:	AstraZeneca
Information provided by:	AstraZeneca

Purpose

Randomized, double-blind, parallel-group, placebo-controlled, multi-centre study to assess ZD4054 in pain-free or mildly symptomatic patient with prostate cancer and bone metastases who have rising serum prostate specific antigen (PSA)

Condition	Treatment or Intervention	Phase
Prostate Cancer	Drug: ZD4054	Phase II

MedlinePlus related topics: Prostate Cancer

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment

Official Title: Randomized, Double-blind, Parallel-group, Placebo-controlled, Multi-centre Study to Assess ZD4054 in Pain-free or Mildly symptomatic Patients with Prostate Cancer and Bone Metastases who have Rising Serum Prostate Specific Antigen (PSA)

Eligibility

Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Male

Criteria

Inclusion Criteria:

Surgically or medically castrated
Bone metastasis
Rising PSA

Exclusion Criteria:

Opiate use
Prior chemotherapy

Location and Contact Information

AstraZeneca Information Center (8 AM – 7 PM EST) 1-800-236-9933

Arizona
Research Site, Tucson, Arizona, United States; Recruiting

Research Site, Gleason, Arizona, United States; Recruiting

California
Research Site, Los Angeles, California, United States; Recruiting

Illinois
Research Site, Chicago, Illinois, United States; Recruiting

Research Site, Chodak, Illinois, United States; Recruiting

Maryland
Research Site, Baltimore, Maryland, United States; Recruiting

Ohio
Research Site, Cleveland, Ohio, United States; Recruiting

More Information

Study ID Numbers: D4320C00006; Trial 6; ZD4054
Record last reviewed: February 2005
Last Updated: February 23, 2005
Record first received: August 25, 2004
ClinicalTrials.gov Identifier: NCT00090363
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08

Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

Edit your listing (whenever you want!)
Link to your website
Choose which categories you are listed in
Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register > 2. Edit Listings > 3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888

No Thanks

Acne Treatment	ADHD Treatment	Allergy Treatment	Alzheimer's Treatment
Anemia Treatment	Arthritis Treatment	Asthma Treatment	Bipolar Disorder Treatment
Bird Flu Treatment	Bladder Cancer Treatment	Bladder Control Treatment	Blood Pressure Treatment
Brain Tumor Treatment	Breast Cancer Treatment	Bronchitis Treatment	Cancer Treatment
Cancer Alternative Treatment	Cataract Treatment	Cirrhosis Treatment	Colitis Treatment
Colon Cancer Treatment	Common Cold Treatment	Conjunctivitis Treatment	Constipation Treatment
Crohn's Disease Treatment	Cystic Fibrosis Treatment	Depression Treatment	Dermatitis Treatment
Diabetes Treatment	Edema Treatment	Epilepsy Treatment	Erectile Dysfunction Treatment
Fibromyalgia Treatment	GERD Treatment	Glaucoma Treatment	Gout Treatment
Hay Fever Treatment	Headache Treatment	Heart Disease Treatment	Hepatitis Treatment
High Blood Pressure Treatment	High Cholesterol Treatment	Hives Treatment	Hypertension Treatment
Hypoglycemia Treatment	IBS Treatment	Impotence Treatment	Indigestion Treatment
Infertility Treatment	Influenza Treatment	Insomnia Treatment	Lactose Intolerance Treatment
Leukemia Treatment	Lung Cancer Treatment	Lyme Disease Treatment	Macular Degeneration Treatment
Menopause Treatment	Migraine Treatment	Osteoarthritis Treatment	Osteoporosis Treatment
Pancreatic Cancer Treatment	PMS Treatment	Pneumonia Treatment	Prostate Diseases Treatment
Restless Leg Treatment	Rheumatoid Arthritis Treatment	Sepsis Treatment	Sinusitis Treatment
Skin Cancer Treatment	Sleep Apnea Treatment	Snoring Treatment	Stroke Treatment
Testicular Cancer Treatment

ZD4054 in Pain-free or Mildly Symptomatic Patients with Prostate Cancer and Bone Metastases who have Rising Serum Prostate Specific Antigen (PSA) - Article

General Topics A-Z

Prostate Diseases

Benign Prostatic Hypertrophy; Prostate Disease; Prostate Enlargement; Prostatitis

Clinical Trial: ZD4054 in Pain-free or Mildly Symptomatic Patients with Prostate Cancer and Bone Metastases who have Rising Serum Prostate Specific Antigen (PSA)

Jump to Section

Purpose

Eligibility

Location and Contact Information

More Information

Take control over your directory listings...INSTANTLY

Limited Time Offer!!!

Popular Treatments

ZD4054 in Pain-free or Mildly Symptomatic Patients with Prostate Cancer and Bone Metastases who have Rising Serum Prostate Specific Antigen (PSA) - Article

General Topics A-Z

Prostate Diseases

Benign Prostatic Hypertrophy; Prostate Disease; Prostate Enlargement; Prostatitis

Clinical Trial: ZD4054 in Pain-free or Mildly Symptomatic Patients with Prostate Cancer and Bone Metastases who have Rising Serum Prostate Specific Antigen (PSA)

Jump to Section

Purpose

Eligibility

Location and Contact Information

More Information

Take control over your directory listings...INSTANTLY

Limited Time Offer!!!

Popular Treatments

Sign Up Now